Kamil Klenha

Statistics

Publications

Citations

H-Index

Active since

2009

Affiliations

The Christie NHS Foundation Trust(Current)

Kamil Klenha is an author at The Christie NHS Foundation Trust specializing in pharmacology, cancer pharmacology, and perennial allergic rhinitis treatment.

Publications per year

2009–2013

Publications

Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial)

Suresh S. Ramalingam, Jeffrey Crawford, Alex Y. Chang et al. · Annals of Oncology · 2013 · 56 citations · Full text

Medicine, Oncology, Pharmacology +9

Rupatadine 10 and 20 mg are effective and safe in the treatment of perennial allergic rhinitis after 4 weeks of treatment: a randomized, double-blind, controlled trial with loratadine and placebo

Marek L. Kowalski, Dariusz Jurkiewicz, Jerzy Kruszewski et al. · Therapy · 2009 · 13 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

1–2 of 2